Skip to content
Recall Observatory FDA recall evidence

Drug product

Irbesartan and Hydrochlorothiazide tablets USP 150 mg/ 12.5 mg, 90-count bottles, Rx only, Manufactured in Israel by: TEVA PHARMACEUTICAL INDUSTRIES LTD Jerusalem, 971010 Israel, Manufactured for: TEVA PHARMACEUTICAL INDUSTRIES USA Sellersville, PA 18960. NDC 0093-8238-98

D-0521-2016

October 20, 2015

Class III

Product summary

Firm
Teva Pharmaceutical Industries
Event
Event 72607
Status
Terminated
Classification
Class III
Quantity
3536 bottles
Official record key
drug-enforcement:D-0521-2016

Official wording

Reason: Labeling: Incorrect or Missing Lot AND/OR Exp Date.

Code information: Lot #: 24I030, Exp 5/2017

Distribution pattern: Nationwide

Derived failure modes

  • Labeling or packaging

    reason.labeling_packaging · v1.0.0

    Labeling: Incorrect or Missing